Nutrition, Metabolism & Cardiovascular Diseases
Volume 18, Issue 1 , Pages 46-56 , January 2008

Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety

  • Vladimir Vuksan

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • Corresponding Author InformationCorresponding author. Risk Factor Modification Centre, St. Michael's Hospital, #6 138-61 Queen Street East, Toronto, ON M5C 2T2, Canada. Tel.:+1 416 864 5525; fax: +1 416 864 5538.
    • ,
  • Mi-Kyung Sung

      Affiliations

    • Department of Food and Nutrition, Sookmyung Women's University, Seoul, South Korea
    • ,
  • John L. Sievenpiper

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • P. Mark Stavro

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • Alexandra L. Jenkins

      Affiliations

    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • Marco Di Buono

      Affiliations

    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • Kwang-Seung Lee

      Affiliations

    • Korea Ginseng Manufacturing Plant, National Agricultural Cooperative Federation, Chung-buk, South Korea
    • ,
  • Lawrence A. Leiter

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada
    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • Ki Yeul Nam

      Affiliations

    • Korean Ginseng and Tobacco Research Institute, Daejeon, South Korea
    • ,
  • John T. Arnason

      Affiliations

    • Department of Biology, Faculty of Science, University of Ottawa, Ottawa, Canada
    • ,
  • Melody Choi

      Affiliations

    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
    • ,
  • Asima Naeem

      Affiliations

    • Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada

Received 10 January 2006 ,Revised 18 April 2006 ,Accepted 19 April 2006.

References 

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79
  3. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–2012
  4. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med. 2002;162:281–287
  5. Angell M, Kassirer JP. Alternative Medicine—the risks of untested and unregulated remedies. N Engl J Med. 1998;339:839–841
  6. Fontanarosa PB, Lundberg GD. Alternative medicine meets science. JAMA. 1998;280:1618–1619
  7. Vuksan V, Xu Z, Jenkins AL, Beljan-Zdravkovic U, Sievenpiper JL, Leiter LA, et al. American Ginseng improves long-term glycemic control in Type 2 diabetes: double-blind placebo controlled crossover trial. American Diabetes Association Annual Meeting. Diabetes. 2000;49(Suppl. 1):A95
  8. Vuksan V, Sievenpiper JL, Xu Z, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, et al. Konjac-mannan and American ginseng: Emerging alternative therapies for type 2 diabetes. J Am Coll Nutr. 2001;20:370s–380s
  9. Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, et al. American ginseng reduces postprandial glycemia in nondiabetic and diabetic individuals. Arch Intern Med. 2000;160:1009–1013
  10. Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care. 2000;23:1221–1226
  11. Vuksan V, Sievenpiper JL, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, et al. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time, but not dose, dependent manner in healthy individuals. Am J Clin Nutr. 2001;73:753–758
  12. Vuksan V, Stavro MP, Sievenpiper JL, Koo VY, Wong E, Beljan-Zdravkovic U, et al. American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. J Am Coll Nutr. 2000;19:738–744
  13. Sievenpiper JL, Sung MK, Di Buono M, Lee KS, Nam KY, Arnason JT, et al. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. J Am Coll Nutr. 2006;25:100–107
  14. Sievenpiper JL, DiBuono M, Stavro PM, Jenkins AL, Nam KY, Choi M, et al. Safety and efficacy of Korean red ginseng Intervention (SAEKI) trial: Rationale, design, and expected findings. In:  Baek Nam-In editors. Advances in Ginseng Research 2002: Proceedings of the 8th International Ginseng Symposium on Ginseng. The Korean Society of Ginseng; 2002;p. 424–455
  15. Wolever TMS, Barbeau MC, Charron S, Harrington K, Leung S, Madrick B, et al. Guidelines for the nutritional management of diabetes mellitus in the new millennium: a position by the Canadian Diabetes Association. CJDC. 2000;23:56–69
  16. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001;47:1985–1992
  17. Johnson PJ. Role of the standard liver function tests in current clinical practice. Ann Clin Biochem. 1989;26:463–471
  18. Kadish AH, Hall DA. A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem. 1965;11:869–875
  19. Liverey JH, Hodgkinson SC, Roud HR, Donald RA. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem. 1980;13:151–155
  20. Fitzloff JF, Yat P, Lu ZZ, Awang DVC, Arnason JT, van Breeman RB, et al. Perspectives on the quality control assurance of ginseng products in North America. In:  Huh H,  Choi KJ,  Kim YC editor. Advances in ginseng research: Proceedings of the 7th International Symposium on Ginseng. Seoul, Korea: Korean Society of Ginseng; 1998;p. 138–145
  21. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470
  22. Haffner SM, Mieettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDMM in Mexican Americans. Diabetes. 1995;44:1386–1391
  23. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158:2200–2211
  24. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136:42
  25. American Diabetes Association . Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(Suppl. 1):s33–s50
  26. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667–687
  27. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions. Life Sci. 2005;77:3344–3354
  28. Yamasaki K, Murakami C, Ohtani K, Kasai R, Kurokawa T, Ishibashi S. Effects of standardized panax ginseng extract G115 on the D-glucose transport by Ehrlich ascites tumour cells. Phytotherapy Res. 1993;7:200–202
  29. Hong SJ, Fong JC, Hwang JH. Effects of crude drugs on glucose uptake in 3T3-L1 adipocytes. Kaohsiung J Med Sci. 2000;16:445–451
  30. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002;51:1851–1858
  31. Hasegawa H, Matsumiya S, Murakami C, Kurokawa T, Kasai R, Ishibashi S, et al. Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes. Planta Med. 1994;60:153–157
  32. Suzuki Y, Ito Y, Konno C, Furuya T. Effects of tissue cultured ginseng on gastric secretion and pepsin activity. [in Japanese] Yakugaku Zasshi. 1991;111:770–774
  33. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26:1277–1294
  34. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 1995;18:1373–1375
  35. Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. Can red ginseng control blood glucose in diabetic patients. Ginseng Rev. 2000;28:44–47
  36. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V. A quantitative systematic analysis of the literature of the high variability in ginseng (Panax spp.): Should it be trusted?. Diabetes Care. 2004;27:839–840
  37. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V. Decreasing, null, and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices: The role of ginsenosides. J Am Coll Nutr. 2004;23:248–258

PII: S0939-4753(06)00109-8

doi: 10.1016/j.numecd.2006.04.003

Nutrition, Metabolism & Cardiovascular Diseases
Volume 18, Issue 1 , Pages 46-56 , January 2008

Article Tools

* Image Usage & Resolution